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background: The beneficial effects of renal sympathetic denervation (RSD) in resistant hypertensive patients may extend beyond blood pressure 
(BP) reduction. In this study, we investigated whether multi-electrode catheter-based RSD has favorable effects on left ventricular structural and 
functional indices, as well as on neurohormonal activation reflected by N-terminal pro B-type natriuretic peptide (NT-proBNP).
methods: Twenty patients with resistant hypertension (age: 57±10years, 13 males, office BP: 180/96±19/16 mmHg under 4.4±0.6 drugs) that 
underwent RSD were followed up for 6 months. A full transthoracic echocardiographic study was performed in all patients at both baseline and 
follow-up. Left ventricular mass was calculated using the Devereux formula and was indexed for body surface area and height, while tissue Doppler 
imaging indices of diastolic function were measured. Moreover, blood sampling was performed in order to estimate NT pro-BNP levels.
results: Apart from office systolic and diastolic BP reduction by -41±19 mmHg and -16±12mmHg, respectively, (p<0.001 for both), RSD decreased 
mean interventricular septum thickness from 12.1±1.2 mm to 11.6±1.2 mm (p=0.04) and left ventricular mass index from 136±20 g/m2 (56.5±8.7 
g/m2.7) to 123±22 g/m2 (51.2±9.2 g/m2.7) (p=0.004) at 6 months. Left atrial diameter and volume were reduced from 42.1±4.3 mm to 
41.0±3.6 mm (p=0.002) and from 62.3±13.5 ml to 51.8±9.5 ml (p=0.001), respectively. Regarding diastolic function RSD caused an increase in 
mitral valve E’/A’ ratio from 0.62±0.28 to 0.82±0.39 (p=0.021) and a decrease in the E/E’ ratio from 14.8±5.9 to 11.7±3.1 (p=0.009), whereas 
isovolumic relaxation time was shortened from 111.1±17.2 ms to 100.7±16.2 ms (p=0.001). Furthermore, RSD resulted in a statistically significant 
reduction in NT-proBNP levels from 85±34.4 pg/ml to 58.6±36.9 pg/ml (p<0.001).
conclusion: In resistant hypertensive patients RSD besides BP reduction causes favorable cardiac remodeling and attenuation of neurohormonal 
overdrive as reflected by decreased NT-proBNP levels. These results suggest pleiotropic cardiovascular benefits of RSD therapy in the setting of 
resistant hypertension.
